The complete package: Sartorius Stedim adds cell bank manufacture 12-Aug-2019 By Maggie Lynch Sartorius Stedim to offer the GMP manufacture of mammalian cell banks for the biopharmaceutical industry alongside characterization services.
Sartorius Stedim BioOutsource adds NBE product characterization to service lineup 24-Jan-2019 By Melissa Fassbender Sartorius Stedim Biotech’s contract testing subsidiary is adding services offer increased support to clients developing new biological entities.
BioOutsource facility passes US FDA inspection 02-Mar-2016 By Gareth Macdonald A laboratory operated by recent Sartorius Stedim Biotech (SSB) acquisition BioOutsoruce has passed a GMP inspection by the US FDA.
Sartorius Stedim Biotech launches new 'nanofleece' prefilters for bioprocessing 05-Dec-2012 Sartorius Stedim Biotech has launched a new ‘fleece-like’ prefiltration technology that it says better protects expensive downstream systems.
SSB signs deal for virus clearance tech SSB signs deal for virus clearance tech 21-Oct-2008 By Nick Taylor Sartorius Stedim Biotech (SSB) and Bayer Technology Services (BTS) have signed an exclusive cooperation agreement for the manufacture and marketing of UVivatec products.